A biotechnology company engaged in the development, production and distribution of innovative drugs created by genetic engineering
Founded in 1980, Amgen Is a leader in the biotechnology industry and one of the first companies to unlock the potential of a new generation of effective and safe drugs and fundamentally new approaches to the treatment of serious diseases.
Amgen drugs have changed everyday medical practice, helping millions of people around the world to deal with severe oncological, hematological and nephrological diseases, rheumatoid arthritis and other serious pathologies. The extensive portfolio of drugs being developed to date (more than 50 new molecules at different stages of development and research) confirms the company’s commitment to using scientific advances to improve people’s lives.
News from Amgen
France and Greece are introducing mandatory vaccination against COVID-19 for doctors. In Russia, vaccination is mandatory for 60% of employees of institutions and enterprises of certain groups, including healthcare sector. […]
The post Doctors do not have enough information about the side effects of vaccines appeared first on GxP News.
The amount of the one-off payment for citizens who have complications after vaccination may be increased, according to RBC. At the moment, this payment is 10,000 rubles, having not been […]
The post The Ministry of Health proposes to increase compensation for complications from vaccination appeared first on GxP News.
The Working Group on the implementation of the regulatory guillotine in the healthcare sector considered the ways to improve the rules for the supply of medicines. The Russian Ministry of […]
The post The Ministry of Health will create a roadmap for improving the drug supply system appeared first on GxP News.
Like 35 years ago, Amgen remains true to its mission:
"Serve patients suffering from severe diseases by developing innovative medicines to meet medical needs."
Amgen LLC, Russia, Moscow, 123112
Presnenskaya naberezhnaya 8, bld.1, fl.7
tel: +7(495)745-0478/79; fax: +7 (499) 995-1965
For information about our pipeline and therapies,
visit our official website